FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Nationwide Laboratories Salsalate Tablets Recall

Salsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18)

Nationwide Laboratories, LLC · Iselin, NJ

Risk level
Class II
Reported by FDA
Dec 7, 2016
Recall ID
D-0165-2017
Check your lot numberHow we source this data

Summary

Nationwide Laboratories recalled Salsalate Tablets starting Oct 28, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0165-2017 on Dec 7, 2016. Reason: CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures. Status: Terminated.

Why it was recalled

CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

Product description

Salsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18); b) 100 count bottles (NDC 42937-703-10); and c) 1000 count bottles (NDC 42937-703-20); Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830.

Lot numbers, UPCs & expiration codes

Lot #: a) 28121501, 28121502, 28121503, 28121504, Exp 03/17; 28121505, Exp 06/17; 28121506, 28121507, Exp 09/17; b) 28121503, 28121504, Exp 03/17; 28121505, Exp 06/17; 28121506, 28121507, Exp 09/17; c) 28121505, Exp 06/17; 28121506, 28121507, Exp 09/17

Where it was sold

Nationwide in USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0165-2017
Classification
Class II
Status
Terminated
Recall initiated
Oct 28, 2016
FDA report date
Dec 7, 2016
Quantity
2,882,661 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
Nationwide Laboratories, LLC

Original FDA data

Every field from FDA enforcement report D-0165-2017, exactly as published.

Show all FDA fields
City
Iselin
State
NJ
Status
Terminated
Country
United States
Event ID
75655
Address
33 Wood Ave S Ste 600
Code information
Lot #: a) 28121501, 28121502, 28121503, 28121504, Exp 03/17; 28121505, Exp 06/17; 28121506, 28121507, Exp 09/17; b) 28121503, 28121504, Exp 03/17; 28121505, Exp 06/17; 28121506, 28121507, Exp 09/17; c) 28121505, Exp 06/17; 28121506, 28121507, Exp 09/17
Postal code
08830-2717
Report date
Dec 7, 2016
Product type
Drugs
Recall number
D-0165-2017
Classification
Class II
Recalling firm
Nationwide Laboratories, LLC
Product quantity
2,882,661 tablets
Termination date
May 17, 2018
Reason for recall
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Salsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18); b) 100 count bottles (NDC 42937-703-10); and c) 1000 count bottles (NDC 42937-703-20); Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830.
Distribution pattern
Nationwide in USA and Puerto Rico
Recall initiation date
Oct 28, 2016
Initial firm notification
Letter
Center classification date
Dec 1, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0165-2017, published Dec 7, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls